Opium
drugOn this page
Also known as IDS-NO-001Opium tincturePapaver somniferum resin
Summary
Opium (CHEMBL2107914) is a phase-3 clinical-stage unknown (ATC N02AA02); indicated across 3 conditions including opiate dependence and short bowel syndrome.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Unknown
- ATC class: N02AA02 (+1 more)
- Indications: 3 conditions
- Clinical trials: 5
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL2107914 |
| Name | Opium |
| Type | Unknown |
| Max phase | 3 |
| ATC | N02AA02, A07DA02 |
Also known as: IDS-NO-001, Opium, Opium tincture, Papaver somniferum resin, OPIUM
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
3 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).
| Indication | Trial phase | MONDO | EFO |
|---|---|---|---|
| opiate dependence | 3 | MONDO:0005530 | EFO:0005611 |
| short bowel syndrome | 3 | MONDO:0015183 | MONDO:0015183 |
1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 5.
Phase distribution
| Phase | Trials |
|---|---|
| PHASE4 | 2 |
| PHASE3 | 1 |
| PHASE2 | 1 |
| Not specified | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT03332056 | PHASE4 | COMPLETED | The Use of Belladonna and Opium Suppository in the Treatment of Postoperative Stent Pain |
| NCT03657407 | PHASE4 | COMPLETED | B&O for TLH Post-operative Pain and Nausea |
| NCT02502175 | PHASE3 | COMPLETED | Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder |
| NCT05690321 | PHASE2 | COMPLETED | Opium Tincture Against Chronic Diarrhea - Patients |
| NCT05702190 | Not specified | COMPLETED | Opium Tincture Against Chronic Diarrhea - Healthy |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
- Diseases: opiate dependence, short bowel syndrome